1. Nishimura RA, Otto CM, Bonow RO, Carabello BA et al.American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Jun 10;63(22):e57-185. doi: 10.1016/j.jacc.2014.02.536.2
2. Falk V, Baumgartner H, Bax JJ, De Bonis M et al. ESC Scientific Document Group.2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg. 2017 Oct 1;52(4):616-664. doi: 10.1093/ejcts/ezx324.
3. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O'Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017 Jun 20;135(25):e1159-e1195. doi: 10.1161/CIR.0000000000000503.
4. Mewton N1, Liu CY, Croisille P, Bluemke D, Lima JA. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol. 2011 Feb 22;57(8):891-903. doi: 10.1016/j.jacc.2010.11.013.
5. Chin CW1, Vassiliou V, Jenkins WS, Prasad SK, Newby DE, Dweck MR. Markers of left ventricular decompensation in aortic stenosis. Expert Rev Cardiovasc Ther. 2014 Jul;12(7):901-12. doi: 10.1586/14779072.2014.923307.
6. Rader F, Sachdev E, Arsanjani R, Siegel RJ. Left ventricular hypertrophy in valvular aortic stenosis: mechanisms and clinical implications. Am J Med. 2015 Apr;128(4):344-52. doi: 10.1016/j.amjmed.2014.10.054.
7. Chin CWL, Pawade TA, Newby DE, Dweck MR. Risk stratification in patients with aortic stenosis using novel imaging approaches. Circ Cardiovasc Imaging 2015;8:e003421.
8. Everett RJ, Stirrat CG, Semple SIR, Newby DE, Dweck MR, Mirsadraee S. Assessment of myocardial fibrosis with T1 mapping MRI. Clin Radiol 2016;71:768–7
9. Badiani S, van Zalen J, Treibel TA, Bhattacharyya S, Moon JC, Lloyd G. Aortic Stenosis, a Left Ventricular Disease: Insights from Advanced Imaging. Curr Cardiol Rep. 2016 Aug;18(8):80. doi: 10.1007/s11886-016-0753-6.
10. Fulton N, Rajiah P. Utility of magnetic resonance imaging in the evaluation of left ventricular thickening. Insights Imaging. 2017 Apr;8(2):279-293. doi: 10.1007/s13244-017-0549-2.
11. Everett RJ, Clavel MA, Pibarot P, Dweck MR.Timing of intervention in aortic stenosis: a review of current and future strategies. Heart. 2018 Dec;104(24):2067-2076. doi: 10.1136/heartjnl-2017-312304.
12. Reiter U, Reiter C, Kräuter C, Fuchsjäger M, Reiter G. Cardiac magnetic resonance T1 mapping. Part 2: Diagnostic potential and applications. Eur J Radiol. 2018 Dec;109:235-247. doi: 10.1016/j.ejrad.2018.10.013.
13. Torvald Espeland, Ida Gjervold Lunde, Brage H. Amundsen, Lars Gullestad, Svend Aakhus. Myocardial fibrosis. Tidsskr Nor Legeforen 2018, doi: 10.4045/tidsskr.17.1027
14. Podlesnikar T, Delgado V, Bax JJ. Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease. Int J Cardiovasc Imaging. 2018 Jan;34(1):97-112. doi: 10.1007/s10554-017-1195
15. Chen H1, Zeng J1, Liu D1, Yang Q2. Prognostic value of late gadolinium enhancement on CMR in patients with severe aortic valve disease: a systematic review and meta-analysis. Clin Radiol. 2018 Nov;73(11):983.e7-983.e14. doi: 10.1016/j.crad.2018.07.095.
16. Bing R, Cavalcante JL, Everett RJ, Clavel MA, Newby DE, Dweck MR.Imaging and Impact of Myocardial Fibrosis in Aortic Stenosis. JACC Cardiovasc Imaging. 2019 Feb;12(2):283-296. doi:10.1016/j.jcmg.2018.11.026.
17. De Rubeis G Galea N, Ceravolo I, Dacquino GM, Carbone I, Catalano C, Francone M. Aortic valvular imaging with cardiovascular magnetic resonance: seeking for comprehensiveness. Br J Radiol. 2019 Sep;92(1101):20170868. doi: 10.1259/bjr.20170868.
18. Debl, K., Djavidani, B., Buchner, S. et al, Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis. Heart. 2006;92:1447–1451
19. Rudolph A, Abdel-Aty H, Bohl S, et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodelling. J Am Coll Cardiol. 2009;53:284–91. doi: 10.1016/j.jacc.2008.08.064.
20. Weidemann, F., Herrmann, S., Stork, S. et al, Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation. 2009;120:577–584
21. Nassenstein K, Bruder O, Breuckmann F, Erbel R, Barkhausen J, Schlosser T. Prevalence, pattern, and functional impact of late gadolinium enhancement in left ventricular hypertrophy due to aortic valve stenosis. Rofo. 2009 May;181(5):472-6. doi: 10.1055/s-0028-1109044.
22. Nigri M, Azevedo CF, Rochitte CE, Schraibman V, Tarasoutchi F et al. Contrast-enhanced magnetic resonance imaging identifies focal regions of intramyocardial fibrosis in patients with severe aortic valve disease: Correlation with quantitative histopathology. Am Heart J. 2009 Feb;157(2):361-8. doi: 10.1016/j.ahj.2008.09.012.
23. Azevedo CF, Nigri M, Higuchi ML, et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol 2010;56:278–87.
24. Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010;122:138–44.
25. Dweck MR, Joshi S, Murigu T, et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol 2011 Sep 13;58(12):1271-9. doi: 10.1016/j.jacc.2011.03.064.
26. Andrew Jabbour,Tevfik F Ismail, Callum Ettles, Carl Shakespeare et al. Potential of pre-contrast T1 mapping as a marker of interstitial fibrosis in severe aortic stenosis. J Cardiovasc Magn Reson. 2012; 14(Suppl 1): O72. Published online 2012 Feb 1. doi: 10.1186/1532-429X-14-S1-O72
27. Dweck MR, Joshi M, Murigu T, et al. Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14:50. doi: 10.1186/1532-429X-14-50.
28. Quarto, C., Dweck, M.R., Murigu, T. et al, Late gadolinium enhancement as a potential marker of increased perioperative risk in aortic valve replacement. Interact Cardiovasc Thorac Surg. 2012;15:45–50
29. Steadman, C.D., Jerosch-Herold, M., Grundy, B. et al, Determinants and functional significance of myocardial perfusion reserve in severe aortic stenosis. JACC Cardiovasc Imaging. 2012;5:182–189
30. Flett AS, Sado DM, Quarta G, et al. Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging 2012;13:819–26.
31. Sado DM1, Flett AS, Banypersad SM, White SK, et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart. 2012 Oct;98(19):1436-41. doi: 10.1136/heartjnl-2012-302346.
32. Fontana M, White SK, Banypersad SM, et al. Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR. J Cardiovasc Magn Reson. 2012;14:88. doi: 10.1186/1532-429X-14-88.
33. Lee, S.P., Park, S.J., Kim, Y.J. et al, Early detection of subclinical ventricular deterioration in aortic stenosis with cardiovascular magnetic resonance and echocardiography. J Cardiovasc Magn Reson. 2013;15:72
34. Bull S, White SK, Piechnik SK, et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart 2013;99:932–7.
35. White S.K., Sado D.M., Fontana M. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. J Am Coll Cardiol Img. 2013;6:955–962.
36. Park J, Chang HJ, Choi JH, et al. Late gadolinium enhancement in cardiac MRI in patients with severe aortic stenosis and preserved left ventricular systolic function is related to attenuated improvement of left ventricular geometry and filling pressure after aortic valve replacement. Korean Circ J. 2014;44(5):312–9. doi: 10.4070/kcj.2014.44.5.312.
37. Mahmod M, Piechnik SK, Levelt E, et al. Adenosine stress native T1 mapping in severe aortic stenosis: evidence for a role of the intravascular compartment on myocardial T1 values. J Cardiovasc Magn Reson 2014;16:92.
38. Dusenbery SM, Jerosch-Herold M, Rickers C, Colan SD, Geva T, Newburger JW, Powell AJ. Myocardial extracellular remodeling is associated with ventricular diastolic dysfunction in children and young adults with congenital aortic stenosis. J Am Coll Cardiol. 2014; 63:1778–1785. doi: 10.1016/j.jacc.2013.11.066.
39. Barone-Rochette G, Piérard S, de Meester de Ravenstein C, et al. Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement. J Am Coll Cardiol 2014; 64: 144–54.
40. Hoffmann R, Alito E, Friedman Z, et al. Myocardial deformation imaging by two-dimensional speckle-tracking echocardiography in comparison to late gadolinium enhancement cardiac magnetic resonance for analysis of myocardial fibrosis in severe aortic stenosis. Am J Cardiol. 2014; 114(7):1083–8. doi: 10.1016/j.amjcard.2014.07.018.
41. Shah AS, Chin CW, Vassiliou V, et al. Left ventricular hypertrophy with strain and aortic stenosis. Circulation 2014;130:1607–16. doi:10.1161/CIRCULATIONAHA.114.011085
42. Chin CWL, Semple S, Malley T, et al. Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis. Eur Heart J Cardiovasc Imaging 2014;15:556–65.
43. Treibel T, Fontana M, Reant P, et al. T1 mapping in severe aortic stenosis: insights into LV remodeling. J Cardiovasc Magn Reson. 2015;17. doi:10.1186/1532-429X-17-S1-089.
44. de Meester de RavensteinC, Bouzin C, Lazam S, et al. Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from modified look-locker imaging (MOLLI) T1 mapping at 3 T. J Cardiovasc Magn Reson. 2015;17:48. doi: 10.1186/s12968-015-0150-0.
45. Singh A, Horsfield MA, Bekele S, Khan J, Greiser A, McCann GP. Myocardial T1 and extracellular volume fraction measurement in asymptomatic patients with aortic stenosis: reproducibility and comparison with age-matched controls. Eur Heart J Cardiovasc Imaging. 2015;16:763–70.
46. Gabriela Liberato, Juliana Bello, Rodrigo D Melo, Antonildes N Assunção Jr, et al. Myocardial extracellular volume fraction and myocardial fibrosis by cmr in patients with severe aortic stenosis. J Cardiovasc Magn Reson. 2015; 17(Suppl 1): P290. Published online 2015 Feb 3. doi: 10.1186/1532-429X-17-S1-P290
47. Emmanuelle Vermes, Nicolas Cazeneuve, Olivier Genee et al.T1 mapping, ECV and ICV before and after aortic valve replacement. J Cardiovasc Magn Reson. 2015; 17(Suppl 1): P342. Published online 2015 Feb 3. doi: 10.1186/1532-429X-17-S1-P342
48. Lee S-P, Lee W, Lee JM, et al. Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis. Radiology 2015;274:359–69.
49. Kockova R., Kacer P., Pirk J. Native T1 relaxation time and extracellular volume fraction as accurate markers of diffuse myocardial fibrosis in heart valve disease- comparison with targeted left ventricular myocardial biopsy. Circ J. 2016;80:1202–1209.
50. Vassilis Vassiliou, Katharina Wassilew, George Asimakopoulos et al. Histological validation of a new CMR T1-mappingbased protocol to improve accuracy for fibrosis assessment in patients with aortic stenosis. Journal of Cardiovascular Magnetic Resonance 2016, 18(Suppl 1):Q56 http://www.jcmr-online.com/content/18/S1/Q56
51. Chin CW, Messika-Zeitoun D, Shah AS et al. A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis. Eur Heart J. 2016 Feb 21;37(8):713-23. doi: 10.1093/eurheartj/ehv525.
52. Rajesh, G.N., Thottian, J.J., Subramaniam, G. et al, Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis. Indian Heart J. 2017;69:742–750
53. Song I, Ko SM, Yi JG, Chee HK, Kim JS. Differences in Aortic Valve and Left Ventricular Parameters Related to the Severity of Myocardial Fibrosis in Patients with Severe Aortic Valve Stenosis PLoS One. 2017 Jan 27;12(1):e0170939.doi:10.1371/journal.pone.0170939
54. Cavalcante JL, Rijal S, Abdelkarim I, Althouse AD, Sharbaugh MS et al. Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis. J Cardiovasc Magn Reson. 2017 Dec 7;19(1):98. doi: 10.1186/s12968-017-0415-x.
55. Musa TA, Uddin A, Swoboda PP, Fairbairn TA et al. Cardiovascular magnetic resonance evaluation of symptomatic severe aortic stenosis: association of circumferential myocardial strain and mortality. J Cardiovasc Magn Reson. 2017 Feb 8;19(1):13. doi: 10.1186/s12968-017-0329-7.
56. Ji-won Hwang, Sung Mok Kim, Sung-Ji Park, Eun Jeong Cho et al. Assessment of reverse remodeling predicted by myocardial deformation on tissue tracking in patients with severe aortic stenosis: a cardiovascular magnetic resonance imaging study. J Cardiovasc Magn Reson. 2017; 19: 80. Published online 2017 Oct 23. doi: 10.1186/s12968-017-0392-0
57. Chin CWL, Everett RJ, Kwiecinski J, et al. Myocardial fibrosis and cardiac decompensation in aortic stenosis. JACC Cardiovasc Imaging 2017;10:1320–33. doi:10.1016/j.jcmg.2016.10.007
58. Lee, H., Park, J.B., Yoon, Y.E. et al, Noncontrast Myocardial T1 Mapping by Cardiac Magnetic Resonance Predicts Outcome in Patients With Aortic Stenosis. JACC Cardiovasc Imaging. 2018;11:974–983
59. Treibel T.A., Lopez, B., Gonzalez, A. et al, Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients. Eur Heart J. 2018;39:699–709
60. Treibel T.A., Kozor R., Schofield R. Reverse myocardial remodeling following valve replacement in patients with aortic stenosis. J Am Coll Cardiol. 2018;71:860–871.
61. Everett RJ, Tastet L, Clavel MA2 Chin CWL et al. Progression of Hypertrophy and Myocardial Fibrosis in Aortic Stenosis: A Multicenter Cardiac Magnetic Resonance Study. Circ Cardiovasc Imaging. 2018 Jun;11(6):e007451. doi: 10.1161/CIRCIMAGING.117.007451.
62. Child N., Suna G., Dabir D. Comparison of MOLLI, shMOLLLI, and SASHA in discrimination between health and disease and relationship with histologically derived collagen volume fraction. Eur Heart J Cardiovasc Imaging. 2018;19:768–776.
63. Fehrmann A, Treutlein M, Rudolph T, Rudolph V et al. Myocardial T1 and T2 mapping in severe aortic stenosis: Potential novel insights into the pathophysiology of myocardial remodelling. Eur J Radiol. 2018 Oct;107:76-83. doi: 10.1016/j.ejrad.2018.08.016.
64. Musa TA1, Treibel TA2, Vassiliou VS3, Captur G2 et al. Myocardial Scar and Mortality in Severe Aortic Stenosis. Circulation. 2018 Oct 30;138(18):1935-1947. doi: 10.1161/CIRCULATIONAHA.117.032839.